Causes and Diagnostic Approach for Polyserositis

Overview of Polyserositis

The European Society of Cardiology recommends considering systemic conditions that affect multiple serous cavities, such as hypothyroidism, malignancy, renal failure, and systemic autoimmune diseases, in the primary differential diagnosis of polyserositis 1

Hypothyroidism is the main metabolic cause of pericardial effusion, occurring in 5-30% of patients with hypothyroidism, though tamponade is rare, according to the European Heart Journal 1
Pericardial effusion occurs in up to 20% of patients with end-stage renal disease (ESRD), with two distinct forms: uremic pericarditis and dialysis-associated pericarditis, as reported by the European Heart Journal 2, 3
Malignant pericardial effusions commonly occur with lung cancer, breast cancer, leukemia, and lymphoma, resulting from direct tumor extension, metastatic spread, or complications of chemotherapy and radiation, according to the Journal of the American College of Cardiology 4
Pericardial involvement is common in systemic lupus erythematosus, Sjögren's syndrome, rheumatoid arthritis, and scleroderma, with approximately 5-15% of patients with acute or recurrent pericarditis having an underlying systemic autoimmune disease, as stated by the European Heart Journal 3

Malignancy is the most common cause of exudative effusions, accounting for 26% of all pleural effusions, with lung cancer, breast cancer, and lymphoma being the leading malignancies, according to the Journal of the American College of Cardiology 4
Parapneumonic effusions/empyema represent 16% of all pleural effusions, with pH <7.2 indicating complicated parapneumonic effusion requiring drainage, as reported by the European Heart Journal 5

The European Heart Journal recommends checking TSH immediately, as hypothyroidism is a reversible cause of polyserositis, and assessing renal function, including BUN, creatinine, and dialysis status 1, 3
The Journal of the American College of Cardiology suggests evaluating for malignancy, including history of cancer, constitutional symptoms, and imaging, and screening for autoimmune disease, such as ANA, RF, and complement levels if clinically indicated 4
The European Heart Journal recommends applying Light's criteria to pleural fluid to distinguish exudate from transudate, and measuring pH, glucose, LDH, protein, and amylase in pleural fluid, with pH <7.2 suggesting infection, rheumatoid arthritis, malignancy, or esophageal rupture 5